Both the biomarkers hs-cTnI and hs-cTnT are independently associated with hypertrophic cardiomyopathy; however, hs-cTnI provides robust information about cardiac hypertrophy [45]. The gene discussed is TNNT2; the disease is cardiac hypertrophy.